Correlative observational study of phase 1 study of RK-163 pulsed human autologous CD14-positive cells (RK-CD14MO) for patients with advanced or relapsed solid tumor
Not Applicable
- Conditions
- Advanced or relapsed solid tumor
- Registration Number
- JPRN-UMIN000032306
- Lead Sponsor
- Keio University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Any patient that the PI/sub-PI deems ineligible to enroll in the study will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-Free Survival
- Secondary Outcome Measures
Name Time Method